Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01110057 | Efficacy Study in Lumbosacral Radiculopathy | PHASE2 | COMPLETED | 142 | — | — | Jan 7, 2010 | Aug 23, 2010 | Jun 8, 2017 | 17 | Denmark, France +3 |
The scores were analyzed based on the 11 point Pain Intensity Numerical Rating Scale (PI-NRS) with 0 score indicating no pain and score of 10 indicating maximum pain. The adjusted mean values are represented as least square mean (LS mean) values.
| Arm | Type | Description |
|---|---|---|
| Active | EXPERIMENTAL | GW856553 |
| Placebo | PLACEBO_COMPARATOR | Placebo |
| Name | Type | Description |
|---|---|---|
| Placebo | DRUG | Placebo to match GW856553 |
| GS856553 | DRUG | GW586553 7.5mg bid |
Key Inclusion Criteria: * Male or female subjects aged 18 - 80 years inclusive, at the time of signing the informed consent. * A female subject is eligible to participate if she is of: Non-childbearing potential defined as pre-menopausal females with a documented tubal ligation or hysterectomy; or...